Showing 381 - 390 of 8410 results

Policy Snapshot

January 12, 2026

CMS Updates Nursing Home Care Compare Following iQIES Transition

The Centers for Medicare & Medicaid Services (CMS) has released Quality & Safety Special Alert Memo QSSAM-26-01-NH to explain recent changes to Nursing Home Care Compare related to the transition to the Internet Quality Improvement and Evaluation System (iQIES). This modernization effort aims to en...
Spotlight

January 8, 2026

Everything You Need to Know for This Year’s Board Election

PALTmed is excited to broaden member engagement in selecting our Board of Directors. This year, the election will be open to all PALTmed members, creating a more inclusive and accessible process for participation. Learn more and view the 2026 Slate of Candidates!
JAMDA

January 7, 2026

Resource Factors Associated With Avoidable Transfers in Nursing Homes

Reducing avoidable hospital transfers among nursing home (NH) residents remains a critical priority, with 20% to 67% of transfers potentially preventable. Despite evidence that embedded advanced practice registered nurses (APRNs) and enhanced resources reduce transfers, chronic underinvestment leaves NHs w...
Spotlight

January 6, 2026

2026 Filkin Lecture Features an Inside Look at State Survey Agencies

Amber Clark-Brown, MD, will be giving the much-anticipated Anne-Marie Filkin Lecture at this year’s PALTC26 annual conference in Anaheim, CA. As the only medical director working within a state survey agency (SSA), Dr. Clark-Brown will offer attendees her unique perspective and insights that she’s excited ...
JAMDA

January 5, 2026

Prescription Patterns and Associated Factors of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Use Among Patients Worldwide: A Systematic Review and Meta-Analysis of Real-World Studies

The prescribing patterns of sodium-glucose cotransporter 2 (SGLT2) inhibitors in real-world clinical practice remain inadequately characterized. To address this gap, this meta-analysis aims to synthesize evidence on the prescription trends and clinical factors associated with SGLT2 inhibitor use.
Policy Snapshot

January 5, 2026

CMS Proposed Model Test Would Lower Drug Costs for Medicare Part D

The Centers for Medicare & Medicaid Services (CMS) announced the newly proposed GUARD (Guarding U.S. Medicare Against Rising Drug Costs) Model that would lower the costs of certain prescription drugs covered by Medicare Part D to reflect prices paid in economically comparable countries.